Saba Capital Management buys $1,976 in Gabelli Healthcare shares
Saba Capital Management, a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), has sold $334,233 worth of ECAT common stock, according to a filing with the SEC dated October 19, 2026. The transaction took place on October 15, 2026, when the investment firm disposed of 24,576 shares of ECAT at a price of $13.60 per share.
Following the sale, Saba Capital Management indirectly holds 12,307,219 shares of the trust. The stock currently trades at $13.19, close to its 52-week low of $13.13, and has fallen nearly 4% over the past week. Despite the recent decline, ECAT offers a substantial dividend yield of 24%. InvestingPro analysis indicates that ECAT pays a significant dividend and is currently trading in oversold territory, which are notable insights for subscribers.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
